FIGS Sees 2026 Net Revenue Surging 20%, Topping Expectations
FIGS has more than doubled off its 52-week low of $6.065.
Summary
FIGS guided for approximately 20% net revenue growth in 2026 over 2025, a strong outlook that signals accelerating demand for its healthcare apparel. This follows a 28% revenue jump in Q1 2026 and a return to profitability, suggesting the brand's direct-to-consumer model is gaining traction. The guidance likely exceeds consensus and could drive upward estimate revisions. With a $1.9B market cap, sustained top-line momentum at this pace would mark a significant inflection. Watch for further color on margins and customer acquisition costs in the next earnings call.
At the time of this announcement, FIGS was trading at $13.11 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $6.07 to $17.48. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.